Titanium vs Absorbable Tacks for Mesh Fixation in Laparoscopic Incisional and Ventral Hernia Repair
LAPAROSCOPIC VENTRAL HERNIA REPAIR BY LIGHTWEIGHT POLYPROPYLENE MESH. A PROSPECTIVE ITALIAN MULTICENTRIC RANDOMIZED STUDY COMPARING TWO FIXATION DEVICES: TITANIUM SPIRAL TACKS vs ABSORBABLE TACKS
1 other identifier
interventional
200
1 country
1
Brief Summary
Background: Laparoscopic repair of ventral hernias has gained popularity, since many studies and a recent meta-analysis have reported encouraging results and recurrence rates similar to open repair. The choice of the mesh and fixation methods is of paramount importance during laparoscopic approach, and nowadays, lightweight macropore meshes specifically designed for laparoscopic approach represent the first choice in several studies, due to the biomechanical properties and the optimal integration into the abdominal wall. No data with statistical relevance exist on the choice of fixation methods. Primary end point of the present Italian multicentric prospective randomized trial is to evaluate the safety and effectiveness of two different tacks to fix the lightweight polypropylene mesh (Physiomesh™) during laparoscopic incisional hernia repair: metallic spiral tacks (Protack™) vs absorbable "U" shaped tacks (Securestrap™) Design of the Study: 200 patients with ventral hernia will be randomized into two groups: Group A patients will be submitted to laparoscopic repair by Physiomesh fixed by Protack; Group B patients will be submitted to laparoscopic repair by Physiomesh fixed by Securestrap. Blind randomization will be guaranteed by an on-line software with specific key access for every surgical unit participating in the study. Patients demographics and characteristics, preoperative studies, intraoperative and postoperative results and complications, as well as scheduled follow-up will be recorded and uploaded to the database. Data represented by continuous variables will be expressed as arithmetic mean +/- standard deviation. Other data will be expressed as geometric mean +/- 95% confidence interval. Data representing low incidence events will be expressed as number and percentage of occurrence for each group. Statistical significance for all analyses will be indicated by a p value of 0.05 or less.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2014
CompletedFirst Posted
Study publicly available on registry
March 4, 2014
CompletedStudy Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJune 1, 2015
May 1, 2015
1.5 years
February 28, 2014
May 29, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
compare mid and long term results in terms of hernia recurrence
The primary outcome measure will be to assess the incidence of hernia recurrence in both study groups
3 years after surgery
Secondary Outcomes (1)
The secondary outcome measure will be the post-operative pain management
1 year after surgery
Study Arms (2)
Group A
OTHERlaparoscopic incisional or ventral hernia repair use of lightweight polypropylene mesh fixed by titanium tacks
Group B
OTHERlaparoscopic incisional or ventral hernia repair use of lightweight polypropylene mesh fixed by U shaped absorbable tacks
Interventions
Eligibility Criteria
You may qualify if:
- L3 Hernia width\*
- No previous vnetral/incisional hernia repair (R0)\*
- No incarcerated/strangulated hernia
- No contaminated field or bowel resection during repair
- BMI \< 35
- Age between 18 and 75 years old
- No severe COPD
- No autoimmune disease under corticosteroids treatment
- No cirrhosis Child B or C
- No uncontrolled diabetic (Glycated Hemoglobin \< 7)
- According to: Muysoms FE, et al. Classification of primary and incisional abdominal wall hernias: Hernia 2009; 13: 407-414
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome
Latina, 04100, Italy
Related Publications (2)
Cavallaro G, Campanile FC, Rizzello M, Greco F, Iorio O, Iossa A, Silecchia G. Lightweight polypropylene mesh fixation in laparoscopic incisional hernia repair. Minim Invasive Ther Allied Technol. 2013 Sep;22(5):283-7. doi: 10.3109/13645706.2013.808228. Epub 2013 Jun 30.
PMID: 23808370BACKGROUNDSilecchia G, Cavallaro G, Raparelli L, Olmi S, Baldazzi G, Campanile FC. Titanium versus absorbable tacks comparative study (TACS): a multicenter, non-inferiority prospective evaluation during laparoscopic repair of ventral and incisional hernia: study protocol for randomized controlled trial. Trials. 2015 Jun 4;16:249. doi: 10.1186/s13063-015-0779-x.
PMID: 26037907DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Gianfranco Silecchia
Study Record Dates
First Submitted
February 28, 2014
First Posted
March 4, 2014
Study Start
June 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2018
Last Updated
June 1, 2015
Record last verified: 2015-05